To purchase articles, go to https://shop.heinonline.org/.
Table of Contents
Reports to the Reader
This Article describes and evaluates two elements of the FDA’s recent operations implicating information transparency: the Transparency Initiative and a reduction in the agency’s FOIA b...read more
The rapidly evolving realm of modern commerce strains traditional regulatory paradigms. This paper traces the historical evolution of FDA crisis-response regulation and provides examples of ways in...read more
FDA warning letters are considered non-final agency actions and thus are not subject to judicial review under the Administrative Procedure Act (APA). The Supreme Court’s analysis in Sackett v...read more
This year the government aggressively pursued Manufacturers under the enhanced provisions of the False Claims Act (FCA), as well as under the provisions of the Food, Drug and Cosmetics Act (FDCA...read more
Second Prize, Short Paper, H. Thomas Austern Memorial Writing Competition, 2011.
While FDA gathers vast amounts of data about prescription drugs prior to their marketing approval, important inform...read more
This article discusses how the Food and Drug Administration has come to adopt informal guidance (agency advice that influences regulated entities but does not carry the force and effect of law) as ...read more
FDA's recent use of the Application Integrity Policy (AIP), most notably in the ongoing Ranbaxy matter, has created interest in the policy. The article discusses actions CDER's Office of Compliance...read more
Animal cloning is “a complex process that lets one exactly copy the genetic, or inherited, traits of an animal.” In 1997, Dolly the sheep was the first animal cloned and since then &ldq...read more
61 Food and Drug Law Journal 13-44 (2006).
In August 2004, President George W. Bush signed the Minor Use and Minor Species Animal Health Act of 2004 (MUMSA) into law. The purpose of this "animal o...read more